Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Powell

Showing results (931-940 of 1,069) with videos related to

Pageof 107
Sort By:
Clinical Immunology (Orlando, Fla.)|January 15, 2016
The low EOMES/TBX21 molecular phenotype in multiple sclerosis reflects CD56+ cell dysregulation and is affected by immunomodulatory therapiesFiona C McKay, Prudence N Gatt, Nicole Fewings, et al.
Diabetologia|March 12, 2020
Slow progressors to type 1 diabetes lose islet autoantibodies over time, have few islet antigen-specific CD8<sup>+</sup> T cells and exhibit a distinct CD95<sup>hi</sup> B cell phenotypeStephanie J Hanna, Wendy E Powell, Anna E Long, et al.
The American Journal of Pathology|January 15, 2016
Spatiotemporal Characterization of the Cellular and Molecular Contributors to Liver Fibrosis in a Murine Hepatotoxic-Injury ModelMichelle Melino, Victoria L Gadd, Kylie A Alexander, et al.
BMJ Open|May 25, 2019
Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT)Mark D Lyttle, Julia A Bielicki, Sam Barratt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2011
Biomarker analysis in a phase III study of pemetrexed-carboplatin versus etoposide-carboplatin in chemonaive patients with extensive-stage small-cell lung cancerE F Smit, M A Socinski, B P Mullaney, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 3, 2014
Antibody stabilization of peptide-MHC multimers reveals functional T cells bearing extremely low-affinity TCRsKatie Tungatt, Valentina Bianchi, Michael D Crowther, et al.
BMJ Open Respiratory Research|February 27, 2023
International perspective on research priorities and outcome measures of importance in the care of children with acute exacerbations of asthma: a qualitative interview studyCharmaine S Gray, Yao Xu, Franz E Babl, et al.
ACS Pharmacology & Translational Science|August 15, 2024
Radiosynthesis and Evaluation of 11C-Labeled Isoindolone-Based Positive Allosteric Modulators for Positron Emission Tomography Imaging of Metabotropic Glutamate Receptor 2Yinlong Li, Kenneth Dahl, Peter Johnström, et al.
Cell|April 3, 2012
The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressorAnne E Powell, Yang Wang, Yina Li, et al.
Neuroimage|April 25, 2008
[11C]AZ10419369: a selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brainM Edward Pierson, Jan Andersson, Svante Nyberg, et al.
Pageof 107

Showing results (931-940 of 1,069) with videos related to

Sort By:
Pageof 107
Clinical Immunology (Orlando, Fla.)|January 15, 2016
The low EOMES/TBX21 molecular phenotype in multiple sclerosis reflects CD56+ cell dysregulation and is affected by immunomodulatory therapiesFiona C McKay, Prudence N Gatt, Nicole Fewings, et al.
Diabetologia|March 12, 2020
Slow progressors to type 1 diabetes lose islet autoantibodies over time, have few islet antigen-specific CD8<sup>+</sup> T cells and exhibit a distinct CD95<sup>hi</sup> B cell phenotypeStephanie J Hanna, Wendy E Powell, Anna E Long, et al.
The American Journal of Pathology|January 15, 2016
Spatiotemporal Characterization of the Cellular and Molecular Contributors to Liver Fibrosis in a Murine Hepatotoxic-Injury ModelMichelle Melino, Victoria L Gadd, Kylie A Alexander, et al.
BMJ Open|May 25, 2019
Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT)Mark D Lyttle, Julia A Bielicki, Sam Barratt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2011
Biomarker analysis in a phase III study of pemetrexed-carboplatin versus etoposide-carboplatin in chemonaive patients with extensive-stage small-cell lung cancerE F Smit, M A Socinski, B P Mullaney, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 3, 2014
Antibody stabilization of peptide-MHC multimers reveals functional T cells bearing extremely low-affinity TCRsKatie Tungatt, Valentina Bianchi, Michael D Crowther, et al.
BMJ Open Respiratory Research|February 27, 2023
International perspective on research priorities and outcome measures of importance in the care of children with acute exacerbations of asthma: a qualitative interview studyCharmaine S Gray, Yao Xu, Franz E Babl, et al.
ACS Pharmacology & Translational Science|August 15, 2024
Radiosynthesis and Evaluation of 11C-Labeled Isoindolone-Based Positive Allosteric Modulators for Positron Emission Tomography Imaging of Metabotropic Glutamate Receptor 2Yinlong Li, Kenneth Dahl, Peter Johnström, et al.
Cell|April 3, 2012
The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressorAnne E Powell, Yang Wang, Yina Li, et al.
Neuroimage|April 25, 2008
[11C]AZ10419369: a selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brainM Edward Pierson, Jan Andersson, Svante Nyberg, et al.
Pageof 107